You are here
Bayer considering sale of its diabetes device business
BAYER AG is exploring the sale of its diabetes device business as the German company focuses on faster-growing medicines, according to people with knowledge of the matter.
Leverkusen, Germany-based Bayer is working with Credit Suisse Group AG on the potential sale, three of
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org